← Eichor
Condition: Hcv Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Hcv

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Digitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy in Chinese
Phase N/A · 1 location(s) · Ruijin Hospital · NCT05870969Acceptability of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users in Non-conventional Structures
Phase N/A · 1 location(s) · University Hospital, Limoges · NCT05361603Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
Phase 2 · 13 location(s) · National Institute of Diabetes and Digestive and Kidney Dise · NCT05832229Blood Collection Biorepository for Liver Disease Research
Phase N/A · 1 location(s) · State University of New York at Buffalo · NCT03025074Clinical Performance Evaluation of MagIA IVD-MD Multiplex Testing (HIV/HBV/HCV/Syphilis)
Phase N/A · 2 location(s) · MagIA Diagnostics · NCT07170748Prophylaxis With Direct-acting Antivirals for Kidney Transplantation From HCV-Infected Donors to Uninfected Recipients
NA · 9 location(s) · Johns Hopkins University · NCT05653232The National Australian HCV Point-of-Care Testing Program - HCV Antibody Testing Minimal Dataset
Phase N/A · 12 location(s) · Kirby Institute · NCT05713136Transplant of Redeemed Organs by Judicious Administration of New Direct-Acting Antivirals for Hepatitis-C Heart Recipien
Phase 2 · 3 location(s) · Baylor Research Institute · NCT03383419ETHOS ENGAGE: Enhancing Treatment of Hepatitis C in Opioid Substitution Settings
NA · 32 location(s) · Kirby Institute · NCT03685045Effect of Some Drugs on Liver Fibrosis
Phase 3 · 1 location(s) · Sherief Abd-Elsalam · NCT03770936Partner Navigation Intervention for Hepatitis C Treatment Among Young People Who Inject Drugs
NA · 1 location(s) · University of California, San Francisco · NCT06179498Abbreviated Magnetic Resonance Imaging vs Ultrasound Surveillance for Liver Cancer dETection in People at High Risk of D
Phase N/A · 2 location(s) · University of Oxford · NCT06658782Persuasive Health Communication Intervention for HIV/HCV
NA · 1 location(s) · University of South Florida · NCT05968573Drug-Drug Intercations and Direct Acting Antiviral Agents Against HCV
Phase N/A · 4 location(s) · University of Seville · NCT06928259The Efficacy of Vosevi in Treating DAA-experienced Patients
Phase N/A · 1 location(s) · The Third Affiliated Hospital of Guangzhou Medical Universit · NCT06180590A Setting Focus Overdose Prevention Intervention
NA · 1 location(s) · Johns Hopkins Bloomberg School of Public Health · NCT05320835Characterization of Immune Genotypes and Antibody Profiles to Foster the discoVERY of diagnosticbioMARKERS of Liver Canc
Phase N/A · 4 location(s) · Centro di Riferimento Oncologico - Aviano · NCT06718530Hepatitis C Pharmacist, Physician, Patient Navigator Collaborative Care Model in Permanent Supportive Housing
NA · 1 location(s) · University of Washington · NCT07667101Enhancing Uptake of Needle and Syringe Programs in Canadian Federal Prisons
NA · 9 location(s) · McGill University Health Centre/Research Institute of the Mc · NCT07122219Hepatitis C Tracker Study
NA · 2 location(s) · University of Southern California · NCT06870019The Treatment in Pregnancy for Hepatitis C ("TiP-HepC") Registry
Phase N/A · 1 location(s) · The Task Force for Global Health · NCT05368974Nation-wide Hepatitis C Virus (HCV) Registry in Taiwan
Phase N/A · 1 location(s) · Kaohsiung Medical University Chung-Ho Memorial Hospital · NCT03200379Feasibility and Acceptability of HCV Treatment in Pregnancy
Phase N/A · 2 location(s) · Washington University School of Medicine · NCT06367465Glecaprevir/Pibrentasvir for Post-traumatic Stress Disorder
Phase 2/Phase 3 · 1 location(s) · White River Junction Veterans Affairs Medical Center · NCT05637879Acceptability and Feasibility of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users and Vulnerable
Phase N/A · 1 location(s) · University Hospital, Limoges · NCT06904820Treatment as Prevention for Hepatitis C in Iceland
Phase N/A · 1 location(s) · Landspitali University Hospital · NCT02647879Appalachian Partnership to Reduce Disparities (Aim 2)
NA · 1 location(s) · Wake Forest University Health Sciences · NCT04378439Tools to Identify People At Risk or Already Infected with HIV and HCV
NA · 1 location(s) · Fundacion para la Investigacion Biomedica del Hospital Unive · NCT06528626Changes in Bile Acids and Microbiota in Patients With Hepatitis D Treated With Bulvertide
Phase N/A · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT07429864The National Australian HCV Point-of-Care Testing Program - Minimal Dataset
Phase N/A · 11 location(s) · Kirby Institute · NCT05248555
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.